Market Overview:
The global antifungal agents market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of fungal infections, rising demand for effective and safe antifungal drugs, and growing awareness about fungal infections. Superficial Antifungal Infections: This segment accounted for the majority share of the global antifungal agents market in 2017 and is projected to grow at a CAGR of 5.8% from 2018 to 2030. Superficial fungal infections are caused by fungi that affect only the outermost layer of skin (the epidermis). These infections are generally mild and can be treated with over-the-counter medications such as topical creams or ointments. Systemic Antifungal Infections: This segment accounted for a minor share of the global antifungal agents market in 2017 but is projected to grow at a higher CAGR than superficial fungal infections during the forecast period owing to increasing prevalence of serious systemic fungal diseases such as candidiasis, cryptococcosis, histoplasmosis, Aspergillosis, blastomycosis etc., which require treatment with systemic antifungals drugs.
Product Definition:
Antifungal agents are medications that treat and prevent fungal infections. They work by disrupting the cell membrane or inhibiting the growth of the fungus. Antifungal agents are important because they can prevent and treat a variety of serious infections, including those that occur in people with weakened immune systems.
Superficial Antifungal Infections:
Superficial antifungal infections are caused by the growth of yeast, bacteria or fungi that lives on the skin and is called a superficial fungal infection (SFAI). The most common type of SFAI is athlete's foot. However, there are other types such as ringworm, jock itch and toenail fungus among others.
Systemic Antifungal Infections:
Systemic antifungal infections are infections that occur throughout the body, as opposed to local or regional infection. The most common systemic fungal infections include blastomycosis, coccidioidomycosis, and histoplasmosis. Fungal infection is a major underlying cause of morbidity in patients with HIV/AIDS and people undergoing hematopoietic stem cell transplantation.
Application Insights:
Non-agrochemical application dominated the global market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to increasing awareness about health & hygiene among consumers, coupled with rising incidences of skin infections caused by fungi. In addition, there are a number of other factors responsible for driving product demand such as high susceptibility of crops towards fungal infection and rapid development in surgical treatment procedures for onychoides nodosa that also contribute towards segment growth.
The agrochemical application segment is anticipated to witness lucrative growth over the forecast period owing to an increase in demand for crop protection against various diseases including brown germ, Alternaria fungus, powdery mildew and others. The rise in disease pressure on crops has resulted into increased usage of antifungal agents that protect plants from pathogens including bacteria, viruses & parasites as well as fungi which cause damage during plant development or early stages when plants are still tender.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of fungal infections and rising awareness about these treatments. In addition, high adoption of technologically advanced products is also one of the major factors contributing toward regional growth.
Asia Pacific antifungal agents market is anticipated to grow at a lucrative rate over the forecast period owing to increasing healthcare expenditure, rising disposable income and improved access & infrastructure for drugs in this region. Favorable government initiatives such as “One Tablet One Treatment†program are also driving demand for antifungal agents in APAC region which will further boost revenue generation over next eight years to come.
Growth Factors:
- Increasing incidence of fungal infections: The increasing incidence of fungal infections is one of the key growth drivers for the antifungal agents market. Fungal infections are caused by a group of microorganisms that include yeasts, molds, and dermatophytes. These organisms can cause serious health problems in humans, including skin infection, respiratory infection, and blood stream infection. According to the Centers for Disease Control and Prevention (CDC), around 6 million people in the U.S. contract a fungal infection every year and around 1 million people die due to these infections annually worldwide
- Rising prevalence of immunocompromised patients: The rising prevalence of immunocompromised patients is another major growth driver for the antifungal agents market. Immunocompromised patients are more susceptible to develop life-threatening fungal infections than healthy individuals as their immune system is not able to fight off these organisms effectively. According to a study by MarketsandMarkets, the global immunocompromised patient population was estimated at 814 million in 2016 and is expected to reach 1 billion by 2021
Scope Of The Report
Report Attributes
Report Details
Report Title
Antifungal Agents Market Research Report
By Type
Superficial Antifungal Infections, Systemic Antifungal Infections
By Application
Non-agrochemical Application, Agrochemical Application
By Companies
F2G, Thermo Fisher Scientific, Basilea Pharmaceutica, Merck, Sato Pharmaceutical, Amplyx, Astellas Pharma, Sigma-Aldrich Corporation, Kramer Laboratories, Valeant Pharmaceuticals, F2G
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Antifungal Agents Market Report Segments:
The global Antifungal Agents market is segmented on the basis of:
Types
Superficial Antifungal Infections, Systemic Antifungal Infections
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Non-agrochemical Application, Agrochemical Application
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F2G
- Thermo Fisher Scientific
- Basilea Pharmaceutica
- Merck
- Sato Pharmaceutical
- Amplyx
- Astellas Pharma
- Sigma-Aldrich Corporation
- Kramer Laboratories
- Valeant Pharmaceuticals
- F2G
Highlights of The Antifungal Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Superficial Antifungal Infections
- Systemic Antifungal Infections
- By Application:
- Non-agrochemical Application
- Agrochemical Application
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antifungal Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antifungal agents are medications that kill fungi.
Some of the major players in the antifungal agents market are F2G, Thermo Fisher Scientific, Basilea Pharmaceutica, Merck, Sato Pharmaceutical, Amplyx, Astellas Pharma, Sigma-Aldrich Corporation, Kramer Laboratories, Valeant Pharmaceuticals, F2G.
The antifungal agents market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antifungal Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antifungal Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antifungal Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antifungal Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antifungal Agents Market Size & Forecast, 2020-2028
4.5.1 Antifungal Agents Market Size and Y-o-Y Growth
4.5.2 Antifungal Agents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Superficial Antifungal Infections
5.2.2 Systemic Antifungal Infections
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Non-agrochemical Application
6.2.2 Agrochemical Application
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antifungal Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antifungal Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Superficial Antifungal Infections
9.6.2 Systemic Antifungal Infections
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Non-agrochemical Application
9.10.2 Agrochemical Application
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Superficial Antifungal Infections
10.6.2 Systemic Antifungal Infections
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Non-agrochemical Application
10.10.2 Agrochemical Application
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Superficial Antifungal Infections
11.6.2 Systemic Antifungal Infections
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Non-agrochemical Application
11.10.2 Agrochemical Application
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Superficial Antifungal Infections
12.6.2 Systemic Antifungal Infections
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Non-agrochemical Application
12.10.2 Agrochemical Application
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Superficial Antifungal Infections
13.6.2 Systemic Antifungal Infections
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Non-agrochemical Application
13.10.2 Agrochemical Application
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antifungal Agents Market: Competitive Dashboard
14.2 Global Antifungal Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F2G
14.3.2 Thermo Fisher Scientific
14.3.3 Basilea Pharmaceutica
14.3.4 Merck
14.3.5 Sato Pharmaceutical
14.3.6 Amplyx
14.3.7 Astellas Pharma
14.3.8 Sigma-Aldrich Corporation
14.3.9 Kramer Laboratories
14.3.10 Valeant Pharmaceuticals
14.3.11 F2G
